Cytel, Inc.

Cytel, Inc.

Cytel, Inc.

Date Founded



1050 Winter Street,Suite 2700,Waltham, MA 02451

Type of Company



Computer Software
Holding Companies

Company Description

Cytel, Inc. engages in the provision of data-focused clinical research services and software solutions for the design and analysis of clinical trials. Its services include strategic consulting, statistical genetics, biostatistics, CDISC, clinical data management, and medical writing. The company was founded by Cyrus Mehta and Nitin Patel in 1987 and is headquartered in Cambridge, MA.

Contact Data
Trying to get in touch with decision makers at Cytel, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees



Chief Executive Officer & Director

Chief Executive Officer-India

Chief Scientific Officer

Senior Vice President-Research & Product

Senior Vice President-Clinical Research Services

Executive Director

Executive Director

Chief Operating Officer

Board of Directors

Managing Director at New Mountain Capital LLC

Founder at Cytel, Inc.

Former President & Chief Executive Officer, Merck Capital Ventures at Merck & Co., Inc.

Former Chief Executive Officer at Cytel, Inc.

Executive Vice President at PAREXEL International Corp.

Founder at Cytel, Inc.

Partner at Clarus Ventures LLC

Partner at Techammer

Managing Director at New Mountain Capital LLC

Managing Director & President, Private Equity at New Mountain Capital LLC

Paths to Cytel, Inc.
Potential Connections via
Relationship Science
Cytel, Inc.
Recent Transactions
Details Hidden

Cytel, Inc., New Mountain Capital LLC purchase Axio Research LLC

Advisors & Consultants

Consulting Chief Financial Officer at Rive Technology, Inc.

Details Hidden

New York Venture Partners seeks investment opportunities in middle market companies located in the US with an enterprise value of $100 million to $1 billion and market leadership in sustainable growth niches and high barriers to competitive entry. The fund targets companies operating in the fields of education, health care, software, business services, logistics, specialty chemicals, federal services, media, consumer products, financial services and insurance, environmental services, infrastructure and energy. It provides capital for LBOs, add on acquisitions and growth capital requirements with an investment size ranging from $100 to $500 million. It also makes co-investments.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cytel, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cytel, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cytel, Inc..